Redwood City, CA · Founded 2021 · Privately Held (backing)
Provider of immuno-oncology therapies intended to activate the innate immune system to fight cancer. Pheast Therapeutics is based in Redwood City, CA and was founded in 2021. It was valued at $155 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $101 million across 2 recorded rounds; the latest was a $24.6 million early-stage round in Oct 2025.
PMV mark · valuation
$154.6M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$100.6M
Last round
Early Stage VC
Oct 2025
Team — not yet on record
No current team members for Pheast Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pheast Therapeutics with a free account
·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
